Methodology
How Homeapotherapy makes a recommendation
Our decision framework: evidence status, safety, provenance, testing labels, category-specific scoring and a commission firewall.
The short version
We do not ask “which product has the loudest marketing?” We ask what decision is the reader making, which facts change that decision, how trustworthy are those facts, and what would make a reasonable buyer skip the product?
1. Evidence is scoped
A result for one formulation, dose, population or route is not automatically evidence for every product that shares an ingredient name. “Promising” never silently becomes “works.”
2. Safety is separate from benefit
A safety warning is not a low product score, and a benefit claim is not a safety clearance. Both get their own visible treatment.
3. Testing labels mean exactly what they say
- Desk researched: we examined published specs, documentation and sources. We did not use the product.
- Hands-on tested: a real person used the product under a documented method.
- Lab measured: a stated metric was measured with documented equipment/protocol.
If we have not done the latter two, we do not write as if we have.
4. Category scoring is versioned
Different categories need different weights. Red-light hardware emphasizes utility, output transparency, usability, documentation, warranty/returns, regulatory clarity and value. Essential oils emphasize botanical identity, testing transparency, label clarity and source transparency.
Commission weight is always zero.
5. Commerce is downstream of editorial
Merchant destinations live in offer data. A merchant can pay a commission without becoming a better product. We can also disable or replace one merchant destination without rewriting the review.
Source trail
What this page is standing on
- AromatherapyU.S. Food and Drug Administration · retrieved 2026-08-10
- Photobiomodulation (PBM) Devices - Premarket Notification [510(k)] SubmissionsU.S. Food and Drug Administration · retrieved 2026-08-10